Preeclampsia, Biotech Deals, and Drug Pricing
Kilder
- Endpoints: Long ignored by drugmakers, preeclampsia is now a focus for WHO and biopharma
- BioPharma Dive: In the hunt for reverse merger targets, Caribou could be prized game
- Finance: In the hunt for reverse merger targets, Caribou could be prized game - Yahoo Finance
- STAT: STAT+: Roche goes beyond licensing in deal with Chinese biotech
- STAT: Roche inks drug discovery deal with Chinese biotech, focused on molecular glue medicines - STAT
- STAT: STAT+: Pharmalittle: We’re reading about PhRMA suing Trump, biotech frustration over tariffs, and more
- STAT: NIH funding uncertainty thwarts U.S. researchers
- STAT: Why this startup is taking its AI to predict breast cancer risk directly to patients - STAT
- wikimedia: Photo by Shixart1985 / Wikimedia Commons / CC BY 2.0
Oppsummeringen og talen er laget med KI. Kildelenkene viser opphavet og er ikke en anbefaling av TellMe fra mediene.